• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将帕金森特定评分转化为健康状态效用值,以评估成本效用分析。

Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.

机构信息

College of Medicine and Public Health, Flinders University, Adelaide, Australia.

Facultad de Administración y Negocios, Universidad Autonoma de Chile, sede Talca, Chile.

出版信息

Patient. 2018 Dec;11(6):665-675. doi: 10.1007/s40271-018-0317-5.

DOI:10.1007/s40271-018-0317-5
PMID:29876865
Abstract

OBJECTIVES

The aim of this study was to compare the Parkinson's Disease Questionnaire-8 (PDQ-8) with three multi-attribute utility (MAU) instruments (EQ-5D-3L, EQ-5D-5L, and 15D) and to develop mapping algorithms that could be used to transform PDQ-8 scores into MAU scores.

METHODS

A cross-sectional study was conducted. A final sample of 228 evaluable patients was included in the analyses. Sociodemographic and clinical data were also collected. Two EQ-5D questionnaires were scored using Spanish tariffs. Two models and three statistical techniques were used to estimate each model in the direct mapping framework for all three MAU instruments, including the most widely used ordinary least squares (OLS), the robust MM-estimator, and the generalized linear model (GLM). For both EQ-5D-3L and EQ-5D-5L, indirect response mapping based on an ordered logit model was also conducted. Three goodness-of-fit tests were employed to compare the models: the mean absolute error (MAE), the root-mean-square error (RMSE), and the intra-class correlation coefficient (ICC) between the predicted and observed utilities.

RESULTS

Health state utility scores ranged from 0.61 (EQ-5D-3L) to 0.74 (15D). The mean PDQ-8 score was 27.51. The correlation between overall PDQ-8 score and each MAU instrument ranged from - 0.729 (EQ-5D-5L) to - 0.752 (EQ-5D-3L). A mapping algorithm based on PDQ-8 items had better performance than using the overall score. For the two EQ-5D questionnaires, in general, the indirect mapping approach had comparable or even better performance than direct mapping based on MAE.

CONCLUSIONS

Mapping algorithms developed in this study enable the estimation of utility values from the PDQ-8. The indirect mapping equations reported for two EQ-5D questionnaires will further facilitate the calculation of EQ-5D utility scores using other country-specific tariffs.

摘要

目的

本研究旨在比较帕金森病问卷-8(PDQ-8)与三种多属性效用(MAU)工具(EQ-5D-3L、EQ-5D-5L 和 15D),并开发可将 PDQ-8 评分转换为 MAU 评分的映射算法。

方法

进行了一项横断面研究。最终纳入了 228 例可评估患者进行分析。还收集了社会人口统计学和临床数据。使用西班牙关税对两个 EQ-5D 问卷进行评分。在直接映射框架内,使用两种模型和三种统计技术估计了所有三种 MAU 工具的每个模型,包括最常用的普通最小二乘法(OLS)、稳健 MM 估计器和广义线性模型(GLM)。对于 EQ-5D-3L 和 EQ-5D-5L,还基于有序逻辑回归模型进行了间接响应映射。采用三种拟合优度检验来比较模型:平均绝对误差(MAE)、均方根误差(RMSE)和预测与观察效用之间的组内相关系数(ICC)。

结果

健康状态效用评分范围为 0.61(EQ-5D-3L)至 0.74(15D)。PDQ-8 总分为 27.51。PDQ-8 总分与每个 MAU 工具之间的相关性范围为-0.729(EQ-5D-5L)至-0.752(EQ-5D-3L)。基于 PDQ-8 项目的映射算法的性能优于使用总评分。对于两个 EQ-5D 问卷,一般来说,间接映射方法的性能与基于 MAE 的直接映射相当,甚至更好。

结论

本研究中开发的映射算法可从 PDQ-8 中估计效用值。对于两个 EQ-5D 问卷,报告的间接映射方程将进一步促进使用其他特定国家的关税计算 EQ-5D 效用评分。

相似文献

1
Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.将帕金森特定评分转化为健康状态效用值,以评估成本效用分析。
Patient. 2018 Dec;11(6):665-675. doi: 10.1007/s40271-018-0317-5.
2
Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39.糖尿病与生活质量:效用工具与糖尿病-39 结果比较。
Diabetes Res Clin Pract. 2015 Aug;109(2):326-33. doi: 10.1016/j.diabres.2015.05.011. Epub 2015 May 12.
3
Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure.将明尼苏达州心力衰竭生活质量问卷(MLHFQ)映射到心力衰竭患者的 EQ-5D-5L 上。
Health Qual Life Outcomes. 2020 Apr 29;18(1):115. doi: 10.1186/s12955-020-01368-2.
4
Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.将 EORTC QLQ-BR53 中文版映射到 EQ-5D-5L 和 SF-6D 效用评分上。
Patient. 2020 Oct;13(5):537-555. doi: 10.1007/s40271-020-00422-x.
5
Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients.比较非小细胞肺癌患者中EQ-5D-5L、EQ-5D-3L与欧洲癌症研究与治疗组织核心生活质量问卷(EORTC-QLQ-C30)之间的映射关系。
Health Qual Life Outcomes. 2016 Apr 12;14:60. doi: 10.1186/s12955-016-0455-1.
6
Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis.将肾脏病生活质量 36 项简明量表(KDQOL-36)映射到透析患者的 EQ-5D-3L 和 EQ-5D-5L。
Eur J Health Econ. 2019 Nov;20(8):1195-1206. doi: 10.1007/s10198-019-01088-5. Epub 2019 Jul 23.
7
Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.测试替代回归模型以预测效用值:将 QLQ-C30 映射到 EQ-5D-5L 和 SF-6D 上。
Qual Life Res. 2018 Nov;27(11):2823-2839. doi: 10.1007/s11136-018-1981-6. Epub 2018 Sep 1.
8
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.将 ALSFRS-R 和 ALSUI 与运动神经元病患者的 EQ-5D 进行映射。
Value Health. 2018 Nov;21(11):1322-1329. doi: 10.1016/j.jval.2018.05.005. Epub 2018 Jul 26.
9
"Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments".纤维肌痛与生活质量:将修订后的纤维肌痛影响问卷映射到基于偏好的工具
Health Qual Life Outcomes. 2017 May 30;15(1):114. doi: 10.1186/s12955-017-0690-0.
10
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.将 FACT-G、FAACT 和 FACIT-F 的健康相关生活质量评分映射到非小细胞肺癌恶病质的基于偏好的 EQ-5D-5L 效用值上。
Eur J Health Econ. 2019 Mar;20(2):181-193. doi: 10.1007/s10198-017-0930-6. Epub 2017 Sep 25.

引用本文的文献

1
Mapping Kansas City cardiomyopathy, Seattle Angina, and minnesota living with heart failure to the MacNew-7D in patients with heart disease.将堪萨斯城心肌病、西雅图心绞痛和明尼苏达州心力衰竭患者的 MacNew-7D 图谱绘制到心脏病患者中。
Qual Life Res. 2024 Aug;33(8):2151-2163. doi: 10.1007/s11136-024-03676-2. Epub 2024 Jun 5.
2
Health-related quality of life in Parkinson's disease: systematic review and meta-analysis of EuroQol (EQ-5D) utility scores.帕金森病患者的健康相关生活质量:EuroQol (EQ-5D) 效用评分的系统评价和荟萃分析。
Qual Life Res. 2024 Jul;33(7):1781-1793. doi: 10.1007/s11136-024-03646-8. Epub 2024 Apr 6.
3

本文引用的文献

1
The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.条件特异性偏好测量在卫生技术评估中的作用。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):33-41. doi: 10.1007/s40273-017-0546-9.
2
The Use of Mapping to Estimate Health State Utility Values.利用映射法估算健康状态效用值。
Pharmacoeconomics. 2017 Dec;35(Suppl 1):57-66. doi: 10.1007/s40273-017-0548-7.
3
Parkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model Analysis.
Cost-effectiveness analysis of insecticide ban aimed at preventing Parkinson's disease in Central California.
加利福尼亚州中部杀虫剂禁令预防帕金森病的成本效益分析。
Sci Total Environ. 2024 Feb 20;912:168913. doi: 10.1016/j.scitotenv.2023.168913. Epub 2023 Nov 30.
4
Deriving health utility indices from a food allergy quality-of-life questionnaire.从食物过敏生活质量问卷中得出健康效用指数。
Pediatr Allergy Immunol. 2021 Nov;32(8):1773-1780. doi: 10.1111/pai.13604. Epub 2021 Aug 6.
5
Mapping the Chinese Version of the EORTC QLQ-BR53 Onto the EQ-5D-5L and SF-6D Utility Scores.将 EORTC QLQ-BR53 中文版映射到 EQ-5D-5L 和 SF-6D 效用评分上。
Patient. 2020 Oct;13(5):537-555. doi: 10.1007/s40271-020-00422-x.
6
Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure.将明尼苏达州心力衰竭生活质量问卷(MLHFQ)映射到心力衰竭患者的 EQ-5D-5L 上。
Health Qual Life Outcomes. 2020 Apr 29;18(1):115. doi: 10.1186/s12955-020-01368-2.
帕金森症状及与健康相关的生活质量作为成本预测因素:一项采用线性混合模型分析的纵向观察研究。
PLoS One. 2015 Dec 23;10(12):e0145310. doi: 10.1371/journal.pone.0145310. eCollection 2015.
4
Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.从帕金森病问卷PDQ - 39到通用欧洲生活质量量表EQ - 5D - 3L的映射:混合模型的价值
Med Decis Making. 2015 Oct;35(7):902-11. doi: 10.1177/0272989X15584921. Epub 2015 Apr 29.
5
Mapping between 6 Multiattribute Utility Instruments.6种多属性效用工具之间的映射
Med Decis Making. 2016 Feb;36(2):160-75. doi: 10.1177/0272989X15578127. Epub 2015 Apr 3.
6
Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach.使用混合方法对EQ-5D-5L健康状态进行估值和建模。
Med Care. 2017 Jul;55(7):e51-e58. doi: 10.1097/MLR.0000000000000283.
7
From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation.从儿童生活质量量表10项版到儿童健康效用9维度模型:创建一种用于经济评估的独特映射算法。
Health Qual Life Outcomes. 2014 Aug 29;12:134. doi: 10.1186/s12955-014-0134-z.
8
Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D.将 FACT-G 癌症特异性生活质量量表映射到 EQ-5D 和 SF-6D 上。
Health Qual Life Outcomes. 2013 Dec 1;11:203. doi: 10.1186/1477-7525-11-203.
9
Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.15-D 和 EQ-5D-5L 量表在西班牙帕金森病人群样本中的验证和比较。
Qual Life Res. 2014 May;23(4):1315-26. doi: 10.1007/s11136-013-0569-4. Epub 2013 Nov 22.
10
Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities.构建间接效用模型:关于映射获得健康状态效用的原则和实践的一些观察。
Pharmacoeconomics. 2013 Aug;31(8):635-41. doi: 10.1007/s40273-013-0071-4.